Leão Júlia, Lauermann Cristine Aline, Winck Valeria Luiza, Petzhold Cesar Liberato, de Andrade Diego Fontana, Beck Ruy Carlos Ruver
Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia Universidade Federal do Rio Grande do Sul, Avenida Ipiranga, 2752, Porto Alegre, Rio Grande do Sul 90610-000, Brazil; Laboratório de Nanocarreadores e Impressão 3D em Tecnologia Farmacêutica (Nano3D), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brasil.
Laboratório de Nanocarreadores e Impressão 3D em Tecnologia Farmacêutica (Nano3D), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brasil.
Int J Pharm. 2025 Sep 2;684:126134. doi: 10.1016/j.ijpharm.2025.126134.
The implementation of 3D printing technologies in clinical settings depends on formulations that are not only printable and compliant with quality standards but also physicochemical stable and reliable under real-use conditions. This study evaluated the in-use and long-term physicochemical and rheological stability of two hydrogel inks developed for semisolid extrusion (SSE) 3D printing: one containing pimobendan (PBD) and the other a placebo. PBD is a poorly water-soluble drug used to treat canine heart failure, whose formulation challenges highlight the potential of personalised drug delivery. Three batches of each formulation were stored in sterile syringes for 180 days to simulate clinical handling, reuse, and storage. Over time, the inks were assessed for rheology, printability, and reproducibility. Printlets produced from the PBD-loaded ink were also analysed for drug content and dissolution, comprising their physicochemical and biopharmaceutical stability. Despite repeated handling and ambient exposure, the PBD formulation maintained its structure, viscoelasticity, and printability, while the placebo showed a significant decline in viscosity. The drug-loaded ink remained suitable for 3D printing for up to six months, and the resulting printlets also remained stable during storage. These findings confirm the robustness of the PBD formulation and the importance of incorporating both the active pharmaceutical ingredient (API) and excipients directly into the ink. The placebo's instability supports the use of fully preloaded systems as a more reliable alternative. By simulating real-use conditions, this study offers a practical assessment of semisolid 3D printing inks, advancing beyond standard pharmacopeial tests and contributing to the establishment of relevant quality criteria for future clinical implementation. Future studies should focus on evaluating the microbiological stability of the printing inks under different storage conditions, including preservative system challenge tests to determine the most effective approach.
3D打印技术在临床环境中的应用取决于一些配方,这些配方不仅要可打印且符合质量标准,还要在实际使用条件下具有物理化学稳定性和可靠性。本研究评估了两种为半固体挤出(SSE)3D打印开发的水凝胶油墨在实际使用和长期的物理化学及流变学稳定性:一种含有匹莫苯丹(PBD),另一种为安慰剂。PBD是一种用于治疗犬类心力衰竭的水溶性较差的药物,其配方挑战凸显了个性化药物递送的潜力。每种配方的三批样品储存在无菌注射器中180天,以模拟临床处理、重复使用和储存。随着时间的推移,对油墨进行流变学、可打印性和再现性评估。还对由含PBD的油墨制成的打印小样进行了药物含量和溶出度分析,包括其物理化学和生物药剂学稳定性。尽管经过反复处理和暴露于环境中,PBD配方仍保持其结构、粘弹性和可打印性,而安慰剂的粘度则显著下降。含药油墨在长达六个月的时间内仍适合3D打印,并且制成的打印小样在储存期间也保持稳定。这些发现证实了PBD配方的稳健性以及将活性药物成分(API)和辅料直接纳入油墨中的重要性。安慰剂的不稳定性支持使用完全预装系统作为更可靠的替代方案。通过模拟实际使用条件,本研究对半固体3D打印油墨进行了实际评估,超越了标准药典测试,并为未来临床应用建立相关质量标准做出了贡献。未来的研究应侧重于评估不同储存条件下打印油墨的微生物稳定性,包括防腐剂系统挑战试验,以确定最有效的方法。